Using our proprietary platform technology, GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute myeloid leukemia, myeloid dysplastic syndrome, and multiple solid tumors by leveraging our proprietary NK cell engager (TriKE) platform technology. (NASDAQ: GTBP)
Company Details
- Employees
- 9
- Founded
- -
- Address
- 8000 Marina Blvd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.gtbiopharma.com/
- HQ
- Brisbane, California
Gt Biopharma, Inc. Questions
Gt Biopharma, Inc.'s website is https://www.gtbiopharma.com/
Gt Biopharma, Inc.'s LinkedIn profile is https://www.linkedin.com/company/gtbiopharma
Gt Biopharma, Inc. has
9 employees.
View email and phone details for 9
employees at Gt Biopharma, Inc..
Gt Biopharma, Inc.'s industry is
Biotechnology Research
Gt Biopharma, Inc.'s top competitors are
Nugenerex Immuno-Oncology, Inc.,
Phanes Therapeutics, Inc.,
Abdera Therapeutics,
Immunogen, Inc.,
Igm Biosciences, Inc.,
Naya Therapeutics,
Oncomatryx Biopharma,
Revitope,
Allovir,
Adcendo.
Gt Biopharma, Inc.'s categories are Biotechnology Research
Gt Biopharma, Inc.'s founding year is 1973
